Diffuse Large B Cell Non-Hodgkin's Lymphoma in the Vulnerable/Frail Elderly. A Multicentric Randomized Phase II Trial

NCT00911183 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: pegfilgrastim
BIOLOGICAL: rituximab
DRUG: cyclophosphamide
DRUG: liposome-encapsulated doxorubicin citrate
DRUG: prednisone
DRUG: vincristine sulfate

Sponsor

Institut Bergonié

Collaborators

[object Object]